Michaela Mihulová

Michaela Mihulová

Auto-generated profile, based on publicly available information

Michaela Mihulová

Department of Biology and Medical Genetics, 2nd Faculty of Medicine, Charles University and Motol and Homolka University Hospital, Prague, Czech Republic

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2023 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
MGMichael A Gargano
Michael A Gargano
NMNicolas Matentzoglu
Nicolas Matentzoglu
BCBen Coleman
Ben Coleman
EAEunice B Addo-Lartey
Eunice B Addo-Lartey
AAAnna V Anagnostopoulos
Anna V Anagnostopoulos
PRPeter N. Robinson
Peter N. Robinson
The Human Phenotype Ontology (HPO) is a widely used resource that comprehensively organizes and defines the phenotypic features of human disease, enabling computational inference and supporting genomic and phenotypic analyses through semantic similarity and machine learning algorithms. The HPO has widespread applications in clinical diagnostics and translational research, including genomic diagnostics, gene-disease discovery, and cohort analytics. In recent years, groups around the world have developed translations of the HPO from English to other languages, and the HPO browser has been internationalized, allowing users to view HPO term labels and in many cases synonyms and definitions in ten languages in addition to English. Since our last report, a total of 2239 new HPO terms and 49235 new HPO annotations were developed, many in collaboration with external groups in the fields of psychiatry, arthrogryposis, immunology and cardiology. The Medical Action Ontology (MAxO) is a new effort to model treatments and other measures taken for clinical management. Finally, the HPO consortium is contributing to efforts to integrate the HPO and the GA4GH Phenopacket Schema into electronic health records (EHRs) with the goal of more standardized and computable integration of rare disease data in EHRs.

19 May 2020 in Annals of Human Genetics
Verified
Journal Article
Closed access
PDF file
JČJana Čopíková
Jana Čopíková
JPJana Paděrová
Jana Paděrová
VRVěra Románková
Věra Románková
MHMarkéta Havlovicová
Markéta Havlovicová
MBMiroslava Balaščáková
Miroslava Balaščáková
RPRadka Kremlíková Pourová
Radka Kremlíková Pourová

30 April 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MSMartin Schwarz
Martin Schwarz
JGJan Geryk
Jan Geryk
MHMarkéta Havlovicová
Markéta Havlovicová
MMMichaela Mihulová
Michaela Mihulová
MTMarek Turnovec
Marek Turnovec
VMVeronika Moslerová
Veronika Moslerová
Cluster analyzes of facial models of autistic patients aim to clarify whether it is possible to diagnose autism on the basis of facial features and further to stratify the autism spectrum disorder. We performed a cluster analysis of sets of 3D scans of ASD patients (116) and controls (157) using Euclidean and geodesic distances in order to recapitulate the published results on the Czech population. In the presented work, we show that the major factor determining the clustering structure and consequently also the correlation of resulting clusters with autism severity degree is body mass index corrected for age (BMIFA). After removing the BMIFA effect from the data in two independent ways, both the cluster structure and autism severity correlations disappeared. Despite the fact that the influence of body mass index (BMI) on facial dimensions was studied many times, this is the first time to our knowledge when BMI was incorporated into the faces clustering study and it thereby casts doubt on previous results. We also performed correlation analysis which showed that the only correction used in the existing clustering studies—dividing the facial distance by the average value within the face—is not eliminating correlation between facial distances and BMIFA within the facial cohort.

13 August 2026 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MMMichaela Mihulová
Michaela Mihulová
VMVeronika Moslerová
Veronika Moslerová
MSMartin Schwarz
Martin Schwarz
JMJúlia Martinková
Júlia Martinková
KKKarolina Kočandrlová
Karolina Kočandrlová
DTDana Thomasová
Dana Thomasová
Verification and visualization of the possible impact of PKD1 causative variants associated with autosomal dominant polycystic kidney disease (ADPKD) on facial phenotype using three-dimensional (3D) geometric morphometry. Three-dimensional facial scans of 39 adult patients with ADPKD were obtained, together with 3D scans of 39 sex and age matched healthy individuals. The 3D facial scans were processed, and morphometric analyses were performed using geometric morphometry to quantified potential phenotypical traits in ADPKD patients. In ADPKD patients, we observed several statistically significant differences in facial morphology compared with healthy controls. In both sexes, considerable retrusion of the supraorbital arches and, conversely, prominence of the suborbital region were detected. In males, additional retrusion along the entire midline was observed, with significant changes at the nasal tip and chin. In females, the midline showed a tendency toward prominence, although these differences were not significant compared with controls. Asymmetry analysis revealed that males with ADPKD exhibit less pronounced asymmetry, with an asymmetry pattern very similar to that of controls. In contrast, females with ADPKD differ from controls in the midface and lower face, showing laterally reversed asymmetry deviations. Patients in the truncating variant group and non-truncating variant groups showed distinct phenotypic patterns in the forehead, philtrum, and chin areas. Our findings suggest the presence of distinct facial phenotypic traits in ADPKD patients carrying pathogenic PKD1 variants compared with healthy controls. In addition, we observed partial subgroup-specific differences according to sex and mutation type.

19 July 2024 in Orthodontics & Craniofacial Research
Verified
Journal Article
Open access
PPPetra Poláčková
Petra Poláčková
JBJiří Borovec
Jiří Borovec
JVJana Vašáková
Jana Vašáková
MPMatěj Patzelt
Matěj Patzelt
WUWanda Urbanova
Wanda Urbanova
VMVeronika Moslerová
Veronika Moslerová
Aim: To utilize three‐dimensional (3D) geometric morphometry for visualization of the level of facial asymmetry in patients with the oculo‐auriculo‐vertebral spectrum (OAVS).Materials and Methods: Three‐dimensional facial scans of 25 Czech patients with OAVS were processed. The patients were divided into subgroups according to Pruzansky classification. For 13 of them, second 3D facial scans were obtained. The 3D facial scans were processed using geometric morphometry. Soft tissue facial asymmetry in the sagittal plane and its changes in two time spots were visualized using colour‐coded maps with a thermometre‐like scale.Results: Individual facial asymmetry was visualized in all patients as well as the mean facial asymmetry for every Pruzansky subgroup. The mean colour‐coded maps of type I and type IIA subgroups showed no differences in facial asymmetry, more pronounced asymmetry in the middle and the lower facial third was found between type IIA and type IIB (maximum 1.5 mm) and between type IIB and type III (maximum 2 mm). The degree of intensity facial asymmetry in affected middle and lower facial thirds did not change distinctly during the two time spots in all subgroups.Conclusions: The 3D geometric morphometry in OAVS patients could be a useful tool for objective facial asymmetry assessment in patients with OAVS. The calculated colour‐coded maps are illustrative and useful for clinical evaluation.

10 April 2023 in Research Square
Verified
Preprint
Open access
PDF file
DGDavid Geneviève
David Geneviève
VRValentin Ruault
Valentin Ruault
PBPauline Burger
Pauline Burger
JGJohanna Gradels-Hauguel
Johanna Gradels-Hauguel
NRNathalie Ruiz-Pallares
Nathalie Ruiz-Pallares
JMJean-Louis Mandel
Jean-Louis Mandel
We report two series of individuals with DDX3X variations, one (48 individuals) from physicians and one (44 individuals) from caregivers. These two series include several symptoms in common, with fairly similar distribution, which suggests that caregivers’ data are close to physicians’ data. For example, both series identified early childhood symptoms that were not previously described: feeding difficulties, mean walking age and age at first words. Each of the two datasets provide complementary knowledge. We confirmed that symptoms are similar to those in the literature and provide more details on feeding difficulties. Caregivers considered that the symptom attention-deficit/hyperactivity disorder was most worrisome. Both series also reported sleep disturbance. Recently, anxiety has been reported in individuals with DDX3X variants. We strongly suggest that attention-deficit/hyperactivity disorder, anxiety and sleep disorders need to be treated. In addition, we demonstrate preliminary evidence of a mild genome-wide DNA methylation profile in patients carrying mutations in DDX3X.